Epigenetics Interest Group
Epigenetics represents a new frontier in cancer research. Information in the genome exists in at least two forms: genetic and epigenetic. The genetic information provides the blueprint for the manufacture of all the proteins necessary to create a living organism, whereas epigenetic information provides additional instructions on how, where, and when the genetic information will be used. The focus of the Epigenetics Interest Group is on applications of epigenetic approaches in disease detection, risk assessment, and treatment. The group organizes and disseminates information about epigenetics-related conferences, meetings, and webinars and meets in person when appropriate. Please contact Dr. Mukesh Verma (vermam@mail.nih.gov) at 240-276-6889 for more information.
Recent Co-Sponsored Lectures
- "Epigenome Editing as a Tool for Basic Discovery and Therapeutic Intervention" by Jonathan Weissman of the MIT Whitehead Institute, on Wednesday, June 5, at 2:00 p.m. ET.
Useful Resources
- International Human Epigenome Consortium (IHEC): https://ihec-epigenomes.org/welcome/
- Australasian Epigenomic Alliance: https://www.aepia.org.au/
- Epigenomics Common Fund: https://commonfund.nih.gov/epigenomics
- Clinical Trials in Epigenetics: https://clinicaltrials.gov/search (search for specific disease)
Chair
- Mukesh Verma, Ph.D., NCI
Advisor
- Mukesh Verma, Ph.D., NCI
Scientific Focus Areas
Genetics and Genomics
This page was last updated on Thursday, December 12, 2024